{{Rsnum
|rsid=3760396
|Gene=CCL2
|Chromosome=17
|position=34254422
|Orientation=minus
|GMAF=0.1194
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CCL2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 55.4 | 36.9 | 7.7
| HCB | 80.0 | 17.8 | 2.2
| JPT | 88.6 | 11.4 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 80.0 | 17.8 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21514686
|Title=Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese
}}

{{PMID Auto
|PMID=18996102
|Title=Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.
}}

{{PMID Auto
|PMID=23198952
|Title=Association of CXCL1 promoter polymorphism with ischaemic stroke in Korean population.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}